Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Arriva-ProMetic completes phase I trial of rAAT in atopic dermatitis patients

Aug. 19, 2003

Galderma presents new PPARgamma agonists with potential in dermatological disorders

Aug. 12, 2003

Pivotal phase III trial for Cellegesic makes solid progress

Aug. 11, 2003

Astralis cleared to begin phase I testing of Psoraxine in U.S.

Aug. 6, 2003

Durable remission following treatment with i.m. alefacept in chronic plaque psoriasis

July 30, 2003

New phase II study evaluates COL-3 in rosacea

July 29, 2003

Effective treatment of chronic anal fissures reported with topical nifedipine

July 18, 2003

Pivotal European study of Adhibit commences enrollment

July 17, 2003

Noncalcemic vitamin D analogue designed by Wisconsin researchers

July 17, 2003

Apafant effective in UVB-induced dermatitis

July 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...